| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/BJC.1981.218 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC2010797 |
| https://europepmc.org/articles/PMC2010797?pdf=render | ||
| http://www.nature.com/articles/bjc1981218.pdf | ||
| http://www.nature.com/articles/bjc1981218 | ||
| P932 | PMC publication ID | 2010797 |
| P698 | PubMed publication ID | 6170301 |
| P5875 | ResearchGate publication ID | 17016633 |
| P2093 | author name string | R. Williams | |
| B. Portmann | |||
| P. J. Johnson | |||
| M. K. Palmer | |||
| W. M. Melia | |||
| P2860 | cites work | A clinicopathological review of 100 cases of primary malignant tumours of the liver | Q36582078 |
| A staging system for hepatocellular carcinoma: Prognostic factors in Ugandan patients | Q38893845 | ||
| Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations | Q38894302 | ||
| Induction of remission in hepatocellular carcinoma with doxorubicin | Q39485693 | ||
| Serum alpha-feto-protein. I. Immunodiffusion and immuno-assay results in cases of primary cancer of the liver | Q47691683 | ||
| Hepatic artery infusion chemotherapy in hepatoma. | Q55483544 | ||
| Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma | Q66700767 | ||
| [Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver.] | Q68654321 | ||
| Serum-alpha 1-fetoprotein in hepatocellular carcinoma | Q70021130 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| liver cirrhosis | Q147778 | ||
| oncology | Q162555 | ||
| P304 | page(s) | 502-505 | |
| P577 | publication date | 1981-10-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma | |
| P478 | volume | 44 |
| Q33752079 | Alpha-1-acid glycoprotein as potential biomarker for alpha-fetoprotein-low hepatocellular carcinoma |
| Q43030603 | Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II. |
| Q53925058 | Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. |
| Q41856056 | Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma |
| Q34247156 | Enzymatic activity of type 1 iodothyronine deiodinase in selected liver tumors |
| Q38191147 | Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature |
| Q41774466 | Hepatocellular carcinoma imaging |
| Q72738882 | Hepatocellular carcinoma in primary biliary cirrhosis: Detection by α-fetoprotein estimation |
| Q41267430 | Hepatoma in the noncirrhotic liver |
| Q39528390 | MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. |
| Q35606927 | Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma |
| Q93510578 | Spontaneous regression of hepatocellular carcinoma |
| Q37747422 | The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma. |
| Q71622193 | Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors |
| Q55217703 | Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics. |
| Q34537280 | Treatment of hepatocellular carcinoma associated with advanced cirrhosis by transcatheter arterial chemoembolization using autologous blood clot: a preliminary report |
| Q33718951 | Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study |
| Q73595102 | Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein |
| Q35802368 | Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease |
| Q39334033 | miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma |
| Q35896305 | microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma |
Search more.